Giridharan Loghanathan Malarvizhi

Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma

Giridharan Loghanathan Malarvizhi, Archana P. Retnakumari, Shantikumar V. Nair et al. · Nanomedicine Nanotechnology Biology and Medicine · 2014 · 88 citations

Nanomedicine, Drug Targeting, Oncology +9

Radiofrequency Ablation of Drug‐Resistant Cancer Cells Using Molecularly Targeted Carboxyl‐Functionalized Biodegradable Graphene

Abhilash Sasidharan, Amal J. Sivaram, Archana P. Retnakumari et al. · Advanced Healthcare Materials · 2015 · 29 citations

Nanomedicine, Graphene-based Nano-antennas, Graphene Quantum Dot +12

Biomineral Nano-Theranostic agent for Magnetic Resonance Image Guided, Augmented Radiofrequency Ablation of Liver Tumor

Anusha Ashokan, Vijay Harish Somasundaram, Genekehal Siddaramana Gowd et al. · Scientific Reports · 2017 · 28 citations · Full text

Rationally Designed Aberrant Kinase-Targeted Endogenous Protein Nanomedicine against Oncogene Mutated/Amplified Refractory Chronic Myeloid Leukemia

Archana P. Retnakumari, Prasanna Lakshmi Hanumanthu, Giridharan Loghanathan Malarvizhi et al. · Molecular Pharmaceutics · 2012 · 23 citations

Molecular Diagnosis, Secondary Kinase, Engineering +17

A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing

Giridharan Loghanathan Malarvizhi, Parwathy Chandran, Archana P. Retnakumari et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 21 citations

Nanomedicine, Photodynamic Killing, Engineering +8